Treatment of Patients with Advanced Malibnant Tumor by Transfor LAK Cells Combined with rIL-2

Five advanced malignant tumor were treated with LAK cells isolated from human fetal spleen combined with rIL-2. One patient with malignant melanoma had metastasis tumor dispeared in one lung and significantly reduced in the other. The matastasis lesion of one patient with lymphoma de-creased 59% after treatment, a patient with intestinal smooth muscle sarcoma had prolonged relapse by administrated LAK/rIL-2" NO serious effects were observed. The results indicated that LAK/ rIL-2 in the treatment of patient with advanced malignant tumor is effect and safe.